David Jay, Esq.
USA Guide 2024
Band 4 : Litigation: General Commercial
Email address
[email protected]Contact number
+1 973 360 7912Share profile
Band 4
About
Provided by David Jay, Esq.
Practice Areas
Litigation
Class Action Litigation
Pharmaceutical, Medical Device & Health Care Litigation
Career
David Jay is the Managing Shareholder of the New Jersey office and an experienced litigator who handles a wide variety of complex, multi-party commercial cases from inception through settlement, trial and appeal. He has defended consumer fraud, health care, TCPA, data breach, and computer class action claims involving hundreds of millions of dollars and is a founding member of the Class Action Committee of the New Jersey State Bar Association. He has represented major health plans, computer, pharmaceutical, consumer product, chemical and communications companies in a variety of disputes.
Concentrations:
Class action litigation
Complex commercial litigation
Hatch-Waxman litigation
Health care litigation
TCPA litigation
Pharmaceutical licensing disputes
Contract disputes
Insurance coverage litigation
Environmental litigation
Technology litigation
Professional Memberships
Member, New Jersey State Bar Association; Class Action Committee; Co-Chair, 2022-2023; Founding Member; Co-Chair, Work-Life Balance Task Force
Member, Association of the Federal Bar of New Jersey
Former Co-Director of Membership, New Jersey Women Lawyers Association
Member, American Bar Association
Board of Directors, Marlboro Soccer Association
Publications
Listed, Chambers USA Guide, Litigation: General Commercial, 2021-2022
Personal
J.D., cum laude, New York University School of Law, 1995
B.B.A., summa cum laude, University of Massachusetts, 1992
Chambers Review
USA
David Jay represents clients in a range of commercial disputes, including patent infringement claims, breach of contract cases and class actions.
Strengths
Provided by Chambers
"He is an excellent lawyer who I use for complex matters."
"He is an excellent lawyer who I use for complex matters."